Early Onset Type 2 Diabetes and Tirzepatide (SURPASS Post Hoc Analysis)
In this episode of Hormone Insight, we examine a 2024 post hoc analysis published in Diabetes Care.
Exploring Semaglutide: Therapy for Obesity and Heart Failure
Exploring Semaglutide: Dual Action Therapy for Obesity and Heart Failure
Semaglutide vs Canagliflozin for Type 2 Diabetes
In this episode of Hormone Insight, we delve into a major study published in The Lancet Diabetes and Endocrin...
Study Shows Tirzepatide Improves Heart Failure Outcomes and Quality of Life in Obese Patients
In patients with heart failure with preserved ejection fraction (HFpEF) and obesity, tirzepatide significantly reduced the composi...
Intensive Blood-Pressure Control in Patients with Type 2 Diabetes
In patients with type 2 diabetes, intensive blood-pressure control (targeting systolic BP <120 mm Hg) significantly reduce...
Phase 2 trial on Semaglutide
This episode explores the potential of semaglutide, a once-weekly GLP-1...